CapsoVision Return on Tangible Equity 1971-1970 | CV
Current and historical return on tangible equity values for CapsoVision (CV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| CapsoVision Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.192B | $0.000B |
| CapsoVision Inc. is a commercial-stage medical technology company which develops advanced imaging and artificial intelligence technologies which are deployed in its capsule endoscopy solutions. CapsoVision Inc. is based in SARATOGA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.994B | 58.52 |
| Hims & Hers Health (HIMS) | United States | $12.427B | 102.82 |
| Doximity (DOCS) | United States | $10.881B | 50.37 |
| Tempus AI (TEM) | United States | $9.996B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.151B | 0.00 |
| Hinge Health (HNGE) | United States | $3.762B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.600B | 38.22 |
| Privia Health (PRVA) | United States | $2.371B | 162.08 |
| 10x Genomics (TXG) | United States | $1.639B | 0.00 |
| Phreesia (PHR) | United States | $1.613B | 0.00 |
| Enovis (ENOV) | United States | $1.511B | 8.43 |
| Clover Health Investments (CLOV) | United States | $1.450B | 0.00 |
| Schrodinger (SDGR) | United States | $1.441B | 0.00 |
| Omnicell (OMCL) | United States | $1.429B | 26.99 |
| Azenta (AZTA) | United States | $1.231B | 53.80 |
| Evolent Health (EVH) | United States | $1.115B | 95.00 |
| Claritev (CTEV) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Talkspace (TALK) | United States | $0.380B | 113.50 |
| Zepp Health (ZEPP) | Netherlands | $0.349B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.336B | 0.00 |
| Carlsmed (CARL) | $0.325B | 0.00 | |
| TruBridge (TBRG) | United States | $0.314B | 696.33 |
| Health Catalyst (HCAT) | United States | $0.266B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| Outset Medical (OM) | United States | $0.250B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.228B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.151B | 0.00 |
| American Well (AMWL) | United States | $0.132B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.118B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 4.58 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.084B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |